Screener
Globus Medical GMED Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 68.5%+5.8pp | 67.9%+7.3pp | 67.4%+8.5pp | 65.3%+7.2pp | 62.8%+3.1pp | |
| Operating margin | 20.3%+9.6pp | 17.2%+7.0pp | 16.3%+9.7pp | 13.4%+8.7pp | 10.7%+7.7pp | |
| Net margin | 17%+3.4pp | 18.9%+11.5pp | 18.3%+14.2pp | 15.3%+11.6pp | 13.6%+11.8pp | |
| Returns | ||||||
| Return on equity | 11.8%+3.2pp | 13.3%+8.7pp | 12.3%+9.8pp | 10%+7.8pp | 8.6%+7.3pp | |
| Return on invested capital | 12.1%+5.0pp | 11.9%+5.0pp | 11.1%+6.5pp | 9.6%+7.3pp | 7.2%— | |
| Efficiency | ||||||
| Asset turnover | 0.6×+0.1× | 0.6×+0.1× | 0.6×+0.1× | 0.5×+0.1× | 0.5×-0.1× | |
| Liquidity | ||||||
| Current ratio | 4.6×+0.5× | 4.6×+0.1× | 4.3×+1.7× | 4.1×+1.6× | 4.1×+1.7× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -0.4×-0.2× | -0.5×+0.2× | -0.5×+1.1× | -0.4×+1.0× | -0.2×+0.8× | |
| Per Share | ||||||
| Book value per share | $34.71+10.3% | $34.24+17.1% | $33.37+10.1% | $32.49+10.2% | $31.47+8.4% | |
| Valuation | ||||||
| Market capitalization | $10.93B+52.9% | $11.65B+15.7% | $11.69B+3.8% | $7.73B-20.2% | $7.94B-14.1% | |
| Price / earnings | 20.4×+0.4× | 19.9×-34.4× | 21.7×-87.6× | 18.3×-87.6× | 22.3×-205× | |
| Price / sales | 3.5×+0.8× | 3.8×-0.3× | 4×-0.5× | 2.8×-1.1× | 3×-1.1× | |
| Price / book | 2.3×+0.6× | 2.5×0.0× | 2.6×-0.1× | 1.8×-0.6× | 1.8×-0.5× | |
| EV / EBITDA | 11.5×-1.3× | 13.8×-4.9× | 14.9×-10.3× | 11.6×-12.9× | 14.2×-16.0× |
FAQ
- What are Globus Medical's profit margins?
- Globus Medical (GMED) runs a 68.5% gross margin and a 20.3% operating margin, with a 17.0% net margin.
- Where do Globus Medical's ratios come from?
- Every ratio is computed from Globus Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
